1346 related articles for article (PubMed ID: 28582758)
1. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
2. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
3. The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.
Modi S; Soejima M; Levesque MC
Clin Exp Immunol; 2013 Jul; 173(1):8-17. PubMed ID: 23607804
[TBL] [Abstract][Full Text] [Related]
4. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
6. TNF alpha as a therapeutic target in rheumatoid arthritis.
Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
[TBL] [Abstract][Full Text] [Related]
7. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
Sánchez-Ramón S; López-Longo FJ; Carreño L
Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
[TBL] [Abstract][Full Text] [Related]
8. Biological agents in rheumatoid arthritis.
Shankar S; Handa R
J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
[TBL] [Abstract][Full Text] [Related]
9. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies.
Laurent L; Anquetil F; Clavel C; Ndongo-Thiam N; Offer G; Miossec P; Pasquali JL; Sebbag M; Serre G
Ann Rheum Dis; 2015 Jul; 74(7):1425-31. PubMed ID: 24618262
[TBL] [Abstract][Full Text] [Related]
10. Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes.
Varas A; Valencia J; Lavocat F; Martínez VG; Thiam NN; Hidalgo L; Fernández-Sevilla LM; Sacedón R; Vicente A; Miossec P
Arthritis Res Ther; 2015 Jul; 17(1):192. PubMed ID: 26215036
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies for rheumatoid arthritis.
Tremoulet AH; Albani S
Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.
Hu D; Tjon EC; Andersson KM; Molica GM; Pham MC; Healy B; Murugaiyan G; Pochet N; Kuchroo VK; Bokarewa MI; Weiner HL
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30639-30648. PubMed ID: 33203678
[TBL] [Abstract][Full Text] [Related]
13. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis, cytokines and hypoxia. What is the link?
Al-Shukaili AK; Al-Jabri AA
Saudi Med J; 2006 Nov; 27(11):1642-9. PubMed ID: 17106534
[TBL] [Abstract][Full Text] [Related]
15. Selected cytokine pathways in rheumatoid arthritis.
Noack M; Miossec P
Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
[TBL] [Abstract][Full Text] [Related]
16. [Present importance of direct immunologically based intervention strategies using anticytokines in rheumatoid arthritis].
Boehme MW; Gao IK
Z Rheumatol; 1999 Oct; 58(5):251-66. PubMed ID: 10591973
[TBL] [Abstract][Full Text] [Related]
17. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
Boissier MC; Semerano L; Challal S; Saidenberg-Kermanac'h N; Falgarone G
J Autoimmun; 2012 Sep; 39(3):222-8. PubMed ID: 22704962
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis.
Kondo N; Kuroda T; Kobayashi D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681582
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of rheumatoid arthritis: targeting cytokines.
Zwerina J; Redlich K; Schett G; Smolen JS
Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
